Funded Projects › HORIZON
BRIDGE · Breakthrough Regulatory Innovation and Development throuGh sandbox Environments
BRIDGE aims to enhance healthcare innovation in Europe by developing a comprehensive framework for designing and operationalizing regulatory sandboxes. By addressing current regulatory limitations and engaging all stakeholders while ensuring compliance, the project seeks to create adaptable, fit-for-purpose methodologies that strengthen the regulatory ecosystem's capacity to promote healthcare innovation.The project’s objectives include identifying and analysing existing regulatory sandboxes across various domains and maturity levels, to determine how their modules can complement current healthcare regulations. BRIDGE will develop a horizon scanning methodology to continuously identify emerging technologies that challenge existing regulatory systems, analyzing their requirements for potential inclusion in regulatory sandboxes to ensure adaptability within an evolving innovation ecosystem.Through multi-stakeholder consultations, BRIDGE will elaborate and assess case studies, as well as develop operational checklists for module design and evidence packages to guide tailored sandbox launches. The project will also develop the Modular Operational Sandbox for Healthcare Innovation and Compliance (MOSAIC), an architectural model with interconnected modules featuring detailed functional specifications and mapped information flows aligned with specific case studies.Additionally, BRIDGE will engage key stakeholders—including regulatory bodies, industry consortia, HTA bodies, payers, healthcare providers, and patients—in an in-depth analysis, consultation, and consensus-building process to ensure the sandbox approach is comprehensive, functional, and adaptable to future advancements. Finally, the project will deliver comprehensive recommendations for the sandbox methodology’s end-to-end operations, encompassing legal, compliance, policy, and regulatory outputs to provide a robust implementation framework.
Consortium · 41 organisations
VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK N.V.
BE · €1,097,773
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH
DE · €794,100
Lilly Deutschland GmbH
DE
EUROSCAN INTERNATIONAL NETWORK EV
DE · €473,940
MSD R&D INNOVATION CENTRE LIMITED
UK
SANOFI-AVENTIS DEUTSCHLAND GMBH
DE
SANOFI WINTHROP INDUSTRIE
FR
TAKEDA PHARMACEUTICALS INTERNATIONAL AG
CH
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
IL
TEKNOLOGIAN TUTKIMUSKESKUS VTT OY
FI · €519,007
NOVARTIS PHARMA AG
CH
FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES
BE
ACADEMISCH ZIEKENHUIS GRONINGEN
NL · €229,894
MERCK SHARP & DOHME CORP
US
MERCKLE GMBH
DE
F. HOFFMANN-LA ROCHE AG
CH
CSL BEHRING GMBH
DE
Merck, Sharp & Dohme de España, S.A.
ES
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN
DE
THE EUROPEAN ASSOCIATION MEDICAL DEVICES-NOTIFIED BODIES
BE · €110,625
ASTELLAS PHARMA EUROPE BV
NL
Pfizer Healthcare Ireland Unlimited Company
IE
BIOGEN IDEC LIMITED
UK
CHARITE - UNIVERSITAETSMEDIZIN BERLIN
DE · €228,123
PFIZER INC
US
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE
DE · €402,613
Merck Serono Ltd.
UK
SANOFI R&D VACCINS
FR
SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
FR
NOVO NORDISK A/S
DK
ELI LILLY AND COMPANY LTD
UK
FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD M.P.
ES · €270,313
THE EUROPEAN MEDICINES AGENCY
NL · €197,595
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA
BE · €584,063
JANSSEN PHARMACEUTICA NV
BE
UNIVERSITE BOURGOGNE EUROPE
FR · €159,669
Pfizer R&D UK Limited
UK
TECHNISCHE UNIVERSITAET DRESDEN
DE · €132,103
MSD Europe Belgium
BE
MERCK HEALTHCARE KGAA
DE
ELI LILLY AND COMPANY
US
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.